The JAK Inhibitor Safety Conversation

Matthew Zirwas, MD, provides advice to dermatologists discussing the safety of JAK inhibitor therapies due to their controversial black box warning.

Related Keywords

Matthew Zirwas ,Drug Administration ,Society For Dermatology Physician Assistants ,Dermatology Physician Assistants ,Greater Columbus ,